Similarly, costs associated with clinic visits were greater among patients with HIV-associated lipodystrophy than non-lipodystrophy patients, although this did not reach statistical significance.
← all excerpts
The impact of HIV-associated lipodystrophy on healthcare utilization and costs.
1
—
—